CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $73,000 | +25.9% | 10,550 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $58,000 | +1.8% | 10,550 | -7.9% | 0.00% | 0.0% |
| Q3 2016 | $57,000 | -9.5% | 11,450 | -18.5% | 0.00% | 0.0% |
| Q2 2016 | $63,000 | 0.0% | 14,050 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $63,000 | -44.7% | 14,050 | -35.1% | 0.00% | -50.0% |
| Q4 2015 | $114,000 | -17.4% | 21,660 | -9.6% | 0.00% | -33.3% |
| Q3 2015 | $138,000 | -19.3% | 23,960 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $171,000 | -25.0% | 23,960 | -30.1% | 0.00% | -25.0% |
| Q1 2015 | $228,000 | -12.3% | 34,260 | -21.2% | 0.00% | 0.0% |
| Q4 2014 | $260,000 | +16.1% | 43,460 | -4.2% | 0.00% | 0.0% |
| Q3 2014 | $224,000 | +3.7% | 45,360 | -5.5% | 0.00% | 0.0% |
| Q2 2014 | $216,000 | +9.1% | 48,010 | +9.1% | 0.00% | +33.3% |
| Q1 2014 | $198,000 | – | 44,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,109,167 | $7,764,000 | 4.19% |
| JW Asset Management, LLC | 263,881 | $1,847,000 | 1.18% |
| BARD ASSOCIATES INC | 88,515 | $620,000 | 0.28% |
| Ariel Investments | 976,377 | $6,835,000 | 0.08% |
| TFS CAPITAL LLC | 20,896 | $146,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,076,000 | 0.02% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 15,959 | $112,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $84,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $369,000 | 0.01% |
| Spark Investment Management LLC | 20,300 | $142,000 | 0.01% |